Novartis Cardiology
Primary Hyperlipidemia
Novartis Cardiology
Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowering Therapy
- 1,287 views
- August 30, 2024
- 3
Novartis Cardiology
Initiating and Monitoring Patients on a Non-Statin Lipid-Lowering Therapy: Provider Experiences
- 1,304 views
- August 30, 2024
- 2
Novartis Cardiology
Understanding Acquisition and Billing for a Non-Statin Lipid-Lowering Therapy
FEATURING
Bobbi Buell
- 1,203 views
- August 30, 2024
- 6
Novartis Cardiology
Expert Insights on Pivotal Phase 3 and Long-term Trial Data in Primary Hyperlipidemia
FEATURING
Dean G. Karalis,
Merle Myerson
- 899 views
- August 30, 2024
- 3
Novartis Cardiology
Expert Insights on Adding a Non-Statin Lipid-Lowering Therapy in a Real-World Setting
FEATURING
Michael Koren
- 1,339 views
- August 30, 2024
- 8